Last Updated: August 15, 2026

J Molner Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for J MOLNER

J MOLNER has eight approved drugs.

Summary for J Molner

US Patents:	0
Tradenames:	8
Ingredients:	8
NDAs:	8

Drugs and US Patents for J Molner

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
J Molner	SUCCINYLCHOLINE CHLORIDE	succinylcholine chloride	INJECTABLE;INJECTION	210231-001	Jun 4, 2018	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
J Molner	DDAVP	desmopressin acetate	INJECTABLE;INJECTION	018938-001	Mar 30, 1984	AP	RX	Yes	Yes		⤷ Start Trial				⤷ Start Trial
J Molner	LAMOTRIGINE	lamotrigine	TABLET, ORALLY DISINTEGRATING;ORAL	214124-002	Feb 3, 2022	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
J Molner	DDAVP	desmopressin acetate	INJECTABLE;INJECTION	018938-002	Apr 25, 1995		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
J Molner	TIMOLOL MALEATE	timolol maleate	SOLUTION/DROPS;OPHTHALMIC	212592-002	Dec 13, 2021	AT3	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for J Molner

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
J Molner	LYSTEDA	tranexamic acid	TABLET;ORAL	022430-001	Nov 13, 2009	7,947,739	⤷ Start Trial
J Molner	DDAVP	desmopressin acetate	INJECTABLE;INJECTION	018938-001	Mar 30, 1984	3,497,491	⤷ Start Trial
J Molner	LYSTEDA	tranexamic acid	TABLET;ORAL	022430-001	Nov 13, 2009	8,022,106	⤷ Start Trial
J Molner	LYSTEDA	tranexamic acid	TABLET;ORAL	022430-001	Nov 13, 2009	8,809,394	⤷ Start Trial
J Molner	DDAVP	desmopressin acetate	INJECTABLE;INJECTION	018938-001	Mar 30, 1984	5,763,407	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for J MOLNER drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Tablets	650 mg	➤ Subscribe	2011-05-24

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

J Molner

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.